NASDAQ : BMRA
Biomerica, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.74 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 8.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.91M |
| Enterprise Value | 7.50M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 15, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 4.60M |
| Shares Outstanding | 4.60M |
| Shares Change (YoY) | +26.67% |
| Shares Change (QoQ) | +6.20% |
| Owned by Insiders (%) | 8.22% |
| Owned by Institutions (%) | 12.73% |
| Float | 4.22M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.82 |
| Forward PS | n/a |
| PB Ratio | 2.17 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.91 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -113.80% |
| Return on Assets (ROA) | -45.47% |
| Return on Invested Capital (ROIC) | -59.00% |
| Return on Capital Employed (ROCE) | -103.73% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | $86,760 |
| Profits Per Employee | -$100,180 |
| Employee Count | 50 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.77 |
Taxes
| Measure | Value |
|---|
| Income Tax | 26,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -38.35% |
| 50-Day Moving Average | 2.06 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 37.05 |
| Average Volume (20 Days) | 11,910 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 10,485 |
| Short Previous Month | 27,659 |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.45 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.34M |
| Gross Profit | 41,000 |
| Operating Income | -5.43M |
| Pretax Income | -4.98M |
| Net Income | -5.01M |
| EBITDA | -5.36M |
| EBIT | -5.43M |
| Loss Per Share | -$1.63 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.73M |
| Total Debt | 2.33M |
| Net Cash | 407,000 |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 3.65M |
| Book Value Per Share | 0.79 |
| Working Capital | 2.57M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -3.96M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 72,000 |
| Net Borrowing | 500,000 |
| Free Cash Flow | -3.96M |
| FCF Per Share | -$0.86 |
Margins
| Measure | Value |
|---|
| Gross Margin | 0.95% |
| Operating Margin | -125.15% |
| Pretax Margin | -114.87% |
| Profit Margin | -115.47% |
| EBITDA Margin | -123.49% |
| EBIT Margin | -125.15% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.67% |
| Shareholder Yield | -26.67% |
| Earnings Yield | -94.61% |
| FCF Yield | -50.00% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -10.46 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |